Swedish Cancer Institute-Issaquah
Issaquah, Washington, United States
Cancer treatment center in Issaquah, Washington
751 NE Blakely Dr Suite 1090, Issaquah, WA 98029
About Swedish Cancer Institute-Issaquah
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
101
SWOG Cancer Research Network
38
Alliance for Clinical Trials in Oncology
33
ECOG-ACRIN Cancer Research Group
15
Gynecologic Oncology Group
3
NRG Oncology
3
Children's Oncology Group
2
GOG Foundation
2
Wake Forest University Health Sciences
2
Calithera Biosciences, Inc
1
Gilead Sciences
1
Clinical Trials at Swedish Cancer Institute-Issaquah
During the past decade, Swedish Cancer Institute-Issaquah conducted 133 clinical trials. In the 10-year time frame, 133 clinical trials started and 74 clinical trials were completed, i.e. on
average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 49 clinical trials were completed. i.e. 132.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
2007-12-01
Active, not recruiting
427
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
2008-10-01
2014-08-01
Completed
80
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
2008-12-01
Active, not recruiting
133
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Swedish Cancer Institute-Issaquah" #1 sponsor was "National Cancer Institute (NCI)" with 101 trials, followed by "SWOG Cancer Research Network" with 38 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 33 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Gynecologic Oncology Group"
with 15 trials sponsored. Other sponsors include 12 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Swedish Cancer Institute-Issaquah"
#1 collaborator was "National Cancer Institute (NCI)" with 99 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were
collaborators in the rest 34 trials.
Clinical Trials Conditions at Swedish Cancer Institute-Issaquah
According to Clinical.Site data, the most researched conditions in "Swedish Cancer Institute-Issaquah" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Breast Cancer" (7 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Swedish Cancer Institute-Issaquah" in a lesser frequency.
Clinical Trials Intervention Types at Swedish Cancer Institute-Issaquah
Most popular intervention types in "Swedish Cancer Institute-Issaquah" are "Drug" (172 trials), "Other" (118 trials), "Biological" (90 trials), "Procedure" (55 trials) and "Radiation" (23 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (48 trials), "Questionnaire Administration" (35 trials), "Computed Tomography" (32 trials) and "Biospecimen Collection" (29 trials). Other intervention names were less common.
Clinical Trials Genders at Swedish Cancer Institute-Issaquah
The vast majority of trials in "Swedish Cancer Institute-Issaquah" are
176 trials for "All" genders, 28 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Swedish Cancer Institute-Issaquah
Currently, there are NaN active trials in "Swedish Cancer Institute-Issaquah".
undefined are not yet recruiting,
63 are recruiting,
98 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 34 completed trials in Swedish Cancer Institute-Issaquah,
5 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Swedish Cancer Institute-Issaquah, 9 "Phase 1"
clinical trials were conducted, 105 "Phase 2" clinical
trials and 102 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".